Abstract 2022-RA-245-ESGO Table 2

Frozen section as a diagnostic test with final histopathological diagnosis as the gold standard. St

N = 187 Benign Borderline Malignant
Prevalence 33.2% (26.5–40.4%) 12.8% (8.4–18.5%) 54.0% (46.6–61.3%)
Sensitivity 98.4% (91.3–99.9%) 75.0% (53.2–90.2%) 88.1% (80.2–93.7%)
Sensitivity 93.6% (87.7–97.2%) 95.1% (90.6–97.9%) 98.8% (93.7–99.9%)
PPV 88.4% (79.6–93.2%) 69.2% (52.4–82.1%) 98.9% (92.7–99.8%)
NPV 99.2% (94.4–99.8%) 96.3% (92.8–98.1%) 87.6% (80.6–92.4%)